Get the Stockscreener App
23.72
2.53%
0.5846
Dice Therapeutics Inc stock is traded at $23.72, with a volume of 509.
It is up +2.53% in the last 24 hours and down -2.06% over the past month.
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is S011806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in a various immunology indications. It is also developing oral therapeutic candidates targeting a4ß7 integrin for the treatment of inflammatory bowel diseases, as well as targeting aVß1/aVß6 integrin for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
See More
Previous Close:
$23.14
Open:
$22.99
24h Volume:
509
Relative Volume:
0.33
Market Cap:
$N/A
Revenue:
$1.54M
Net Income/Loss:
$-104.24M
P/E Ratio:
-10.14
EPS:
-2.34
Net Cash Flow:
$-87.22M
1W Performance:
+0.07%
1M Performance:
-2.06%
6M Performance:
-50.12%
1Y Performance:
-50.12%
1-Day Range:
$22.99
$23.72
1-Week Range:
$22.99
$24.71
52-Week Range:
$16.94
$47.90
Dice Therapeutics Inc Stock (DICE) Company Profile
Name
Dice Therapeutics Inc
Sector
Industry
Phone
650-566-1402
Address
279 East Grand Avenue, Suite 300 Lobby B, South San Francisco
Compare DICE vs VOO, IVV, SPY, VTI, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DICE
Dice Therapeutics Inc
|
23.72 | 0 | 1.54M | -104.24M | -87.22M | -2.34 |
VOO
Vanguard S P 500 Etf
|
709.43 | 1.05T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
775.16 | 889.50B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
771.79 | 815.11B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
378.42 | 696.97B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
728.00 | 486.89B | 0 | 0 | 0 | 0.00 |
Dice Therapeutics Inc Stock (DICE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-23 | Initiated | Needham | Buy |
| Mar-01-23 | Initiated | Cowen | Outperform |
| Mar-01-23 | Initiated | TD Cowen | Outperform |
| Nov-15-22 | Initiated | Guggenheim | Buy |
| Sep-14-22 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-07-22 | Initiated | Stifel | Buy |
| Jul-18-22 | Initiated | H.C. Wainwright | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Evercore ISI | Outperform |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Dice Therapeutics Inc Stock (DICE) Latest News
Novel ETFs: New Milestones for Crypto, Leverage & Sports - ETF Database
DICE ETF Holdings List — BOATS:DICE - TradingView
DICE ETF Price and Chart — BOATS:DICE - TradingView
Technical Analysis of Tema Trading & Prediction Markets ETF (CBOE:DICE) - TradingView
DICE.BZ Price History for Tema Trading & Prediction Markets Stock - Barchart.com
DICE.BZ Price History for Tema Trading & Prediction Markets Stock - Barchart.com
Anthropic’s Mega-IPO: The Case Behind the $2 Trillion Valuation - Tema ETFs
Tema Trading & Prediction Markets ETF ETF Price, Holdings, & News (BATS:DICE) $DICE - MarketBeat
Don't Bet the Outcome, Own the Platform with DICE - Yahoo Finance
Want Private-Market Access to Kalshi and Polymarket? Try This ETF - The Globe and Mail
Want Private-Market Access to Kalshi and Polymarket? Try This ETF - Yahoo Finance
Want Private-Market Access to Kalshi and Polymarket? Try This ETF - The Globe and Mail
Tema Trading & Prediction Markets ETF Review and Aggregate Rating (DICE) $DICE - MarketBeat
DICE Top Holdings List & Exposure (Tema Trading & Prediction Markets ETF) - MarketBeat
Tema Trading & Prediction Markets ETF (DICE) Chart and Price History 2026 $DICE - MarketBeat
LAZR: The Only ETF Offering More Than 10% Anthropic Exposure - Tema ETFs
Behind the Ticker: DICE Rolls Into Prediction Markets - ETF.com
How to Invest in Anthropic Pre-IPO - Tema ETFs
Tema Trading & Prediction Markets ETF (DICE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Time to Look Up: Why Space Is Worth Revisiting - Tema ETFs
DICE Options Chain — CBOE:DICE - tradingview.com
What to Expect When You’re Expecting… A Mid-Term Election - Tema ETFs
Tema Photonics & Optical ETF (LAZR) Exceeds $100M in AUM Within 3 Months - Tema ETFs
DICE Price History for Tema Trading & Prediction Markets ETF - Barchart.com
Anthropic, Kalshi and Polymarket Before IPOs: ETFs Find a Way inTema Photonics & Optical ETF (ARCA:LAZ - Benzinga
Three ETFs offer rare public access to private prediction market firms like Kalshi amid growing interest. - Pluang
Get Kalshi And Polymarket Exposure With These ETFs - Seeking Alpha
Tema Trading & Prediction Markets ETF (DICE-A) Insider Trade Summaries - The Globe and Mail
Tema Trading & Prediction Markets ETF (DICE-A) Statistics - The Globe and Mail
Novel ETFs: New Strategies Push Boundaries - ETF Database
Watch Tema Rolls 'DICE' On SpaceX, Prediction Markets - Bloomberg.com
DICE ETF Holdings List — CBOE:DICE - tradingview.com
Kalshi and Polymarket Aren’t Public. You Can Still Buy Them Through an ETF. - barrons.com
Eli Lilly's Immunology Push Builds New Growth Engines Beyond GLP-1s - The Globe and Mail
Eli Lilly's Immunology Push Builds New Growth Engines Beyond GLP-1s - TradingView
Tema Launches DICE ETF With Exposure to Kalshi and Polymarket - Bonus.com
Tema ETFs Launches the First Prediction Market ETF - Casino.org
Tema Launches Trading & Prediction Markets ETF (DICE) - Yahoo Finance
Tema Launches Trading & Prediction Markets ETF (DICE) - GlobeNewswire
DICE ETF Profile: Dividends, Returns (CBOE:DICE) - TradingView
Tema ETFs Appoints Paisley Nardini as Head of Investment Strategy - Tema ETFs
Tema ETFs Appoints Paisley Nardini as Head of Investment Strategy - Yahoo Finance
DICE Therapeutics Inc. (DICE) Peer Comparison – Compare with Others - valueresearchonline.com
Ambros Therapeutics Announces Appointments of John C. Jacobs and Scott Robertson to Board of Directors - The Manila Times
White Paper: Know Your HBF: How Big a Deal Is It? - Tema ETFs
Tema ETFs to Update Name and Ticker for Power Semiconductor ETF (SIC) - Tema ETFs
Autoimmune Treatment Market Report Examines Industry Trends, Growth Drivers And Future Outlook - openPR.com
DHI Group (DHX) Stock Sees Fair Value Lift As Analysts Weigh ClearanceJobs And Dice - Yahoo Finance
Segment Overview and Major Growth Areas in the Urokinase Market - openPR.com
Tema ETFs Announces Product Updates - Tema ETFs
Dice Therapeutics Inc Stock (DICE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):